Levesam 1gm Eazy Glide Tablet contains Levetiracetam 1000mg, an antiepileptic medication indicated for the treatment of partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby reducing neuronal excitability and seizure propagation. This tablet formulation is designed for ease of swallowing and rapid onset of action, enhancing patient compliance. Levesam is typically administered as adjunctive therapy in adults and pediatric patients aged four years and above, with dosage individualized based on clinical response and tolerability. Common adverse effects may include somnolence, dizziness, headache, fatigue, and behavioral symptoms such as irritability or agitation. Caution is advised in patients with renal impairment, and dose adjustments may be necessary. Levesam should be used under strict medical supervision, with regular monitoring for efficacy and adverse reactions. It is contraindicated in patients with known hypersensitivity to Levetiracetam or any of the excipients. This medication should not be abruptly discontinued to avoid increased seizure frequency. Levesam 1gm Eazy Glide Tablet offers a reliable therapeutic option for seizure management, contributing to improved quality of life in epileptic patients.